Abiopharma

🔍 Nolan Stephen A (Director)

Company: Quest Resource Holding Corp (QRHC)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 3,097 shares of Common Stock at $1.13 per share (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 95,420.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: H | shares_owned_after: 112,585.00 | Footnotes: F3

Footnotes:

• F1: These reported securities represent deferred stock units ("DSUs") granted under the Issuer's 2024 Incentive Compensation Plan. The shares of common stock underlying such DSUs shall be issued upon the Reporting Person's separation from service with the Issuer.
• F2: The reported securities include (a) 63,059 DSUs granted under the Issuer's 2012 Incentive Compensation Plan and (b) 32,361 DSUs granted under the Issuer's 2024 Incentive Compensation Plan. The shares of common stock underlying such DSUs shall be issued upon the Reporting Person's separation from service with the Issuer.
• F3: Includes (a) 20,000 restricted stock units that are scheduled to fully vest on August 13, 2026 and (b) 92,585 shares of common stock beneficially owned by the Reporting Person, of which 5,000 are held jointly by the Reporting Person and his spouse.